649
Views
14
CrossRef citations to date
0
Altmetric
Clinical Research

Cardiac arrhythmias, electrolyte abnormalities and serum cardiac glycoside concentrations in yellow oleander (Cascabela thevetia) poisoning – a prospective study

, , , &
Pages 104-111 | Received 01 Mar 2018, Accepted 05 Jul 2018, Published online: 03 Aug 2018

References

  • Job C. A retrospective study of poisoning cases in Thrissur district of Kerala for the year 1995. J Indian Soc Toxicol. 2009;5:23–27.
  • Bandara V, Weinstein SA, White J, et al. A review of the natural history, toxinology, diagnosis and clinical management of Nerium oleander (common oleander) and Thevetia peruviana (yellow oleander) poisoning. Toxicon. 2010;56:273–281.
  • Aparna S, Sharmila M. Yellow oleander seed poisoning – a profile. IOSR J Dent Med Sci. 2017;16:64–71.
  • Lucas GN. Plant poisoning in Sri Lankan children: a hospital based prospective study. Sri Lanka J Child Health. 2008;35:111–124.
  • Pirasath S, Arulnithy K. Yellow oleander poisoning in eastern province: an analysis of admission and outcome. Indian J Med Sci. 2013;67:178–183.
  • Roberts DM, Southcott E, Potter JM, et al. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit. 2006;28:784–792.
  • Eddleston M, Warrell DA. Management of acute yellow oleander poisoning. Qjm. 1999;92:483–485.
  • Zamani J, Aslani A. Cardiac findings in acute yellow oleander poisoning. J Cardiovasc Dis Res. 2010;1:27–29.
  • Mandal L. Yellow oleander-Thevetia peruviana-poisoning. Postgrad Med J. 2012;12:52–55.
  • Eddleston M, Ariaratnam CA, Sjostrom L, et al. Acute yellow oleander (Thevetia peruviana) poisoning: cardiac arrhythmias, electrolyte disturbances, and serum cardiac glycoside concentrations on presentation to hospital. Heart. 2000;83:301–306.
  • Rajapakse S. Management of yellow oleander poisoning. Clin Toxicol. 2009;47:206–212.
  • Bose TK, Basu RK, Biswas B, et al. Cardiovascular effects of yellow oleander ingestion. J Indian Med Assoc. 1999;97:407–410.
  • Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomized controlled trial. Lancet. 2008;371:579–587.
  • Eddleston M, Rajapakse S, Rajakanthan, et al. Anti-digoxin Fab fragments in cardiotoxicity induced by ingestion of yellow oleander: a randomised controlled trial. Lancet. 2000; 355:967–972.
  • Eddleston M, Ariaratnam CA, Meyer WP, et al. Epidemic of self-poisoning with seeds of the yellow oleander tree (Thevetia peruviana) in northern Sri Lanka. Trop Med Int Health. 1999;4:266–273.
  • Gunalane L, Govindaraj V, Balasubramanian S, et al. Serum cardiac glycosides concentration as a predictor of cardiac arrhythmias in acute yellow oleander poisoning. JAPI. 2003;51:1199.
  • Lokesh S, Arunkumar R. A clinical study of 30 cases of acute yellow oleander poisoning (Thevetia nerifolia.). J Curr Trends Clin Med Lab Biochem. 2013;1:28–31.
  • Gopalakrishnan SK, Kandasamy S, Isaac B, et al. Oleander Toxicity – the clinical spectrum and mortality predictors: an observational study. INternet J Med Update. 2017;12:4–8.
  • de Silva HA, Fonseka MM, Pathmeswaran A, et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003;361:1935–1938.
  • Roberts DM, Gallapatthy G, Dunuwille A, et al. Pharmacological treatment of cardiac glycoside poisoning. Br J Clin Pharmacol. 2016;81:488–495.
  • Borges LSR. Diagnostic accuracy measures in cardiovascular research. Int J Cardiovasc Sci. 2016;29:218–222.
  • Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM. 2006;8:19–20.
  • Simundic AM. Measures of diagnostic accuracy: basic definitions. Clin Chem Lab Med. 2009;19:203–211.
  • Eddleston M, Dissanayake M, Sheriff MHR, et al. Physical vulnerability and fatal self-harm in the elderly. Br J Psychiatry. 2006;189:278–279.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.